{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:24:25Z","timestamp":1791228265042,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007224","name":"National Foundation for Science and Technology Development","doi-asserted-by":"publisher","award":["108.05-2018.15"],"award-info":[{"award-number":["108.05-2018.15"]}],"id":[{"id":"10.13039\/100007224","id-type":"DOI","asserted-by":"publisher"}]},{"name":"VINBIGDATA","award":["VINIF.2020.TS.128"],"award-info":[{"award-number":["VINIF.2020.TS.128"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s11030-021-10359-4","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T19:05:35Z","timestamp":1642187135000},"page":"2659-2678","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Discovery of small molecular inhibitors for interleukin-33\/ST2 protein\u2013protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7313-9853","authenticated-orcid":false,"given":"Tan Thanh","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuc Gia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh-Tri","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh-Dao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong Nguyen Hoai","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieu-Thuong Thi","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6315-2974","authenticated-orcid":false,"given":"Quoc-Thai","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-9614","authenticated-orcid":false,"given":"Khac-Minh","family":"Thai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"10359_CR1","doi-asserted-by":"publisher","first-page":"14918","DOI":"10.1073\/pnas.1308651110","volume":"110","author":"X Liu","year":"2013","unstructured":"Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, Wang S, Wang X (2013) Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci USA 110:14918\u201314923. https:\/\/doi.org\/10.1073\/pnas.1308651110","journal-title":"Proc Natl Acad Sci USA"},{"key":"10359_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/imr.12619","volume":"281","author":"C Cayrol","year":"2018","unstructured":"Cayrol C, Girard J-P (2018) Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family. Immunol Rev 281:154\u2013168. https:\/\/doi.org\/10.1111\/imr.12619","journal-title":"Immunol Rev"},{"key":"10359_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.5935\/abc.20150151","volume":"106","author":"H Villacorta","year":"2016","unstructured":"Villacorta H, Maisel AS (2016) Soluble ST2 testing: a promising biomarker in the management of heart failure. Arq Bras Cardiol 106:145\u2013152. https:\/\/doi.org\/10.5935\/abc.20150151","journal-title":"Arq Bras Cardiol"},{"key":"10359_CR4","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nri.2016.95","volume":"16","author":"FY Liew","year":"2016","unstructured":"Liew FY, Girard J-P, Turnquist HR (2016) Interleukin-33 in health and disease. Nat Rev Immunol 16:676\u2013689. https:\/\/doi.org\/10.1038\/nri.2016.95","journal-title":"Nat Rev Immunol"},{"key":"10359_CR5","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrd2660","volume":"7","author":"R Kakkar","year":"2008","unstructured":"Kakkar R, Lee RT (2008) The IL-33\/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 7:827\u2013840. https:\/\/doi.org\/10.1038\/nrd2660","journal-title":"Nat Rev Drug Discov"},{"key":"10359_CR6","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1161\/01.cir.0000038705.69871.d9","volume":"106","author":"EO Weinberg","year":"2002","unstructured":"Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S-i, Solomon SD, Rouleau J-L, Lee RT (2002) Expression and regulation of ST2, an Interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 106:2961\u20132966. https:\/\/doi.org\/10.1161\/01.cir.0000038705.69871.d9","journal-title":"Circulation"},{"key":"10359_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.164.2.2008120","volume":"164","author":"K Oshikawa","year":"2001","unstructured":"Oshikawa K, Kuroiwa K, Tago K, Iwahana H, Yanagisawa K, Ohno S, Tominaga S-I, Sugiyama Y (2001) Elevated soluble ST2 protein levels in sera of patients with asthma with an acute exacerbation. Am J Respir Crit Care Med 164:277\u2013281. https:\/\/doi.org\/10.1164\/ajrccm.164.2.2008120","journal-title":"Am J Respir Crit Care Med"},{"key":"10359_CR8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4168\/aair.2011.3.2.81","volume":"3","author":"K Oboki","year":"2011","unstructured":"Oboki K, Nakae S, Matsumoto K, Saito H (2011) IL-33 and airway inflammation. Allergy Asthma Immunol Res 3:81\u201388. https:\/\/doi.org\/10.4168\/aair.2011.3.2.81","journal-title":"Allergy Asthma Immunol Res"},{"key":"10359_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/ibd.21175","volume":"16","author":"CJ Beltran","year":"2010","unstructured":"Beltran CJ, Nunez LE, Diaz-Jimenez D, Farfan N, Candia E, Heine C, Lopez F, Gonzalez MJ, Quera R, Hermoso MA (2010) Characterization of the novel ST2\/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis 16:1097\u20131107. https:\/\/doi.org\/10.1002\/ibd.21175","journal-title":"Inflamm Bowel Dis"},{"key":"10359_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062144","volume":"8","author":"A Latiano","year":"2013","unstructured":"Latiano A, Palmieri O, Pastorelli L, Vecchi M, Pizarro TT, Bossa F, Merla G, Augello B, Latiano T, Corritore G, Settesoldi A, Valvano MR, D\u2019Inc\u00e0 R, Stronati L, Annese V, Andriulli A (2013) Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease. PLoS ONE 8:e62144. https:\/\/doi.org\/10.1371\/journal.pone.0062144","journal-title":"PLoS ONE"},{"key":"10359_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3233\/JAD-132081","volume":"40","author":"Z Xiong","year":"2014","unstructured":"Xiong Z, Thangavel R, Kempuraj D, Yang E, Zaheer S, Zaheer A (2014) Alzheimer\u2019s disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain. J Alzheimers Dis 40:297\u2013308. https:\/\/doi.org\/10.3233\/JAD-132081","journal-title":"J Alzheimers Dis"},{"key":"10359_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/imm.12174","volume":"141","author":"C Pei","year":"2014","unstructured":"Pei C, Barbour M, Fairlie-Clarke KJ, Allan D, Mu R, Jiang HR (2014) Emerging role of interleukin-33 in autoimmune diseases. Immunology 141:9\u201317. https:\/\/doi.org\/10.1111\/imm.12174","journal-title":"Immunology"},{"key":"10359_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3899\/jrheum.090492","volume":"37","author":"Y Matsuyama","year":"2010","unstructured":"Matsuyama Y, Okazaki H, Tamemoto H, Kimura H, Kamata Y, Nagatani K, Nagashima T, Hayakawa M, Iwamoto M, Yoshio T, Tominaga S, Minota S (2010) Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 37:18\u201325. https:\/\/doi.org\/10.3899\/jrheum.090492","journal-title":"J Rheumatol"},{"key":"10359_CR14","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","volume":"49","author":"MY Mok","year":"2010","unstructured":"Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, Lam KF, Xu D (2010) Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 49:520\u2013527. https:\/\/doi.org\/10.1093\/rheumatology\/kep402","journal-title":"Rheumatology"},{"key":"10359_CR15","unstructured":"WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 24 Nov 2021"},{"key":"10359_CR16","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1016\/s2665-9913(20)30340-4","volume":"2","author":"G Zizzo","year":"2020","unstructured":"Zizzo G, Cohen PL (2020) Imperfect storm: is interleukin-33 the Achilles heel of COVID-19? Lancet Rheumatol 2:e779\u2013e790. https:\/\/doi.org\/10.1016\/s2665-9913(20)30340-4","journal-title":"Lancet Rheumatol"},{"key":"10359_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186953","author":"SB Park","year":"2020","unstructured":"Park SB, Kim SJ, Cho SW, Choi CY, Lee S (2020) Blocking of the IL-33\/ST2 signaling axis by a Single-Chain Antibody Variable Fragment (scFv) specific to IL-33 with a defined epitope. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21186953","journal-title":"Int J Mol Sci"},{"key":"10359_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1398-9995.2011.02735.x","volume":"67","author":"YH Kim","year":"2012","unstructured":"Kim YH, Yang TY, Park CS, Ahn SH, Son BK, Kim JH, Lim DH, Jang TY (2012) Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis. Allergy 67:183\u2013190. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02735.x","journal-title":"Allergy"},{"key":"10359_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2009.06.008","volume":"386","author":"X Liu","year":"2009","unstructured":"Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T (2009) Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun 386:181\u2013185. https:\/\/doi.org\/10.1016\/j.bbrc.2009.06.008","journal-title":"Biochem Biophys Res Commun"},{"key":"10359_CR20","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jaci.2019.02.028","volume":"144","author":"A Holgado","year":"2019","unstructured":"Holgado A, Braun H, Van Nuffel E, Detry S, Schuijs MJ, Deswarte K, Vergote K, Haegman M, Baudelet G, Haustraete J, Hammad H, Lambrecht BN, Savvides SN, Afonina IS, Beyaert R (2019) IL-33trap is a novel IL-33\u2013neutralizing biologic that inhibits allergic airway inflammation. J Allergy Clin Immunol 144:204\u2013215. https:\/\/doi.org\/10.1016\/j.jaci.2019.02.028","journal-title":"J Allergy Clin Immunol"},{"key":"10359_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.immuni.2017.09.015","volume":"47","author":"M Osbourn","year":"2017","unstructured":"Osbourn M, Soares DC, Vacca F, Cohen ES, Scott IC, Gregory WF, Smyth DJ, Toivakka M, Kemter AM, le Bihan T, Wear M, Hoving D, Filbey KJ, Hewitson JP, Henderson H, Gonz\u00e0lez-C\u00ecscar A, Errington C, Vermeren S, Astier AL, Wallace WA, Schwarze J, Ivens AC, Maizels RM, McSorley HJ (2017) HpARI protein secreted by a helminth parasite suppresses interleukin-33. Immunity 47:739-751.e5. https:\/\/doi.org\/10.1016\/j.immuni.2017.09.015","journal-title":"Immunity"},{"key":"10359_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/1062936x.2020.1837239","volume":"31","author":"MT Le","year":"2020","unstructured":"Le MT, Mai TT, Huynh PNH, Tran TD, Thai KM, Nguyen QT (2020) Structure-based discovery of interleukin-33 inhibitors: a pharmacophore modelling, molecular docking, and molecular dynamics simulation approach. SAR QSAR Environ Res 31:883\u2013904. https:\/\/doi.org\/10.1080\/1062936x.2020.1837239","journal-title":"SAR QSAR Environ Res"},{"key":"10359_CR23","doi-asserted-by":"publisher","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","volume":"7","author":"J Zhang","year":"2015","unstructured":"Zhang J, Ramadan AM, Griesenauer B, Li W, Turner MJ, Liu C, Kapur R, Hanenberg H, Blazar BR, Tawara I, Paczesny S (2015) ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease. Sci Transl Med 7:308ra160. https:\/\/doi.org\/10.1126\/scitranslmed.aab0166","journal-title":"Sci Transl Med"},{"key":"10359_CR24","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/bcp.14361","volume":"86","author":"I Nnane","year":"2020","unstructured":"Nnane I, Frederick B, Yao Z, Raible D, Shu C, Badorrek P, van den Boer M, Branigan P, Duffy K, Baribaud F, Fink D, Yang T-Y, Xu Z (2020) The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis. Br J Clin Pharmacol 86:2507\u20132518. https:\/\/doi.org\/10.1111\/bcp.14361","journal-title":"Br J Clin Pharmacol"},{"key":"10359_CR25","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99208","author":"AM Ramadan","year":"2018","unstructured":"Ramadan AM, Daguindau E, Rech JC, Chinnaswamy K, Zhang J, Hura GL, Griesenauer B, Bolten Z, Robida A, Larsen M, Stuckey JA, Yang CY, Paczesny S (2018) From proteomics to discovery of first-in-class ST2 inhibitors active in vivo. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.99208","journal-title":"JCI Insight"},{"key":"10359_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2014a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177\u2013182. https:\/\/doi.org\/10.1021\/ci049714+","journal-title":"J Chem Inf Model"},{"key":"10359_CR27","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768. https:\/\/doi.org\/10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"key":"10359_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1021\/ci200097m","volume":"51","author":"DR Koes","year":"2011","unstructured":"Koes DR, Camacho CJ (2011) Pharmer: efficient and exact pharmacophore search. J Chem Inf Model 51:1307\u20131314. https:\/\/doi.org\/10.1021\/ci200097m","journal-title":"J Chem Inf Model"},{"key":"10359_CR29","volume-title":"Version 2015.10","author":"Molecular Operating Environment (MOE)","year":"2015","unstructured":"Molecular Operating Environment (MOE) (2015) Version 2015.10. Chemical Computing Group Inc., Montreal"},{"key":"10359_CR30","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2174\/1568026611313090003","volume":"13","author":"A Voet","year":"2013","unstructured":"Voet A, Banwell EF, Sahu KK, Heddle JG, Zhang KYJ (2013) Protein interface pharmacophore mapping tools for small molecule protein: Protein interaction inhibitor discovery. Curr Top Med Chem 13:989\u20131001. https:\/\/doi.org\/10.2174\/1568026611313090003","journal-title":"Curr Top Med Chem"},{"key":"10359_CR31","doi-asserted-by":"publisher","first-page":"4586","DOI":"10.2174\/138161212802651616","volume":"18","author":"A Voet","year":"2012","unstructured":"Voet A, Zhang KYJ (2012) Pharmacophore modelling as a virtual screening tool for the discovery of SMPPIIs. Curr Pharm Des 18:4586\u20134598. https:\/\/doi.org\/10.2174\/138161212802651616","journal-title":"Curr Pharm Des"},{"key":"10359_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1471-2105-9-40","volume":"9","author":"Y Zhang","year":"2008","unstructured":"Zhang Y (2008) I-TASSER server for protein 3D structure prediction. BMC Bioinform 9:40. https:\/\/doi.org\/10.1186\/1471-2105-9-40","journal-title":"BMC Bioinform"},{"key":"10359_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"J Yang","year":"2015","unstructured":"Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER Suite: protein structure and function prediction. Nat Methods 12:7\u20138. https:\/\/doi.org\/10.1038\/nmeth.3213","journal-title":"Nat Methods"},{"key":"10359_CR34","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725\u2013738. https:\/\/doi.org\/10.1038\/nprot.2010.5","journal-title":"Nat Protoc"},{"key":"10359_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0022-2836(63)80023-6","volume":"7","author":"GN Ramachandran","year":"1963","unstructured":"Ramachandran GN, Ramakrishnan C, Sasisekharan V (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7:95\u201399. https:\/\/doi.org\/10.1016\/S0022-2836(63)80023-6","journal-title":"J Mol Biol"},{"key":"10359_CR36","doi-asserted-by":"publisher","first-page":"W375","DOI":"10.1093\/nar\/gkm216","volume":"35","author":"IW Davis","year":"2007","unstructured":"Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB 3rd, Snoeyink J, Richardson JS, Richardson DC (2007) MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 35:W375\u2013W383. https:\/\/doi.org\/10.1093\/nar\/gkm216","journal-title":"Nucleic Acids Res"},{"key":"10359_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/pro.3330","volume":"27","author":"CJ Williams","year":"2018","unstructured":"Williams CJ, Headd JJ, Moriarty NW, Prisant MG, Videau LL, Deis LN, Verma V, Keedy DA, Hintze BJ, Chen VB, Jain S, Lewis SM, Arendall WB 3rd, Snoeyink J, Adams PD, Lovell SC, Richardson JS, Richardson DC (2018) MolProbity: more and better reference data for improved all-atom structure validation. Protein Sci 27:293\u2013315. https:\/\/doi.org\/10.1002\/pro.3330","journal-title":"Protein Sci"},{"key":"10359_CR38","unstructured":"LeadIT version 2.1.8. http:\/\/www.biosolveit.de\/LeadIT\/. Accessed 10 Dec 2019"},{"key":"10359_CR39","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s11030-016-9688-5","volume":"20","author":"T-D Ngo","year":"2016","unstructured":"Ngo T-D, Tran T-D, Le M-T, Thai K-M (2016) Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds. Mol Divers 20:945\u2013961. https:\/\/doi.org\/10.1007\/s11030-016-9688-5","journal-title":"Mol Divers"},{"key":"10359_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jbi.2005.02.008","volume":"38","author":"TA Lasko","year":"2005","unstructured":"Lasko TA, Bhagwat JG, Zou KH, Ohno-Machado L (2005) The use of receiver operating characteristic curves in biomedical informatics. J Biomed Inform 38:404\u2013415. https:\/\/doi.org\/10.1016\/j.jbi.2005.02.008","journal-title":"J Biomed Inform"},{"key":"10359_CR41","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13321-015-0100-8","volume":"7","author":"C Empereur-mot","year":"2015","unstructured":"Empereur-mot C, Guillemain H, Latouche A, Zagury J-F, Viallon V, Montes M (2015) Predictiveness curves in virtual screening. J Cheminform 7:52. https:\/\/doi.org\/10.1186\/s13321-015-0100-8","journal-title":"J Cheminform"},{"key":"10359_CR42","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1021\/jm300687e","volume":"55","author":"MM Mysinger","year":"2012","unstructured":"Mysinger MM, Carchia M, Irwin JJ, Shoichet BK (2012) Directory of Useful Decoys, Enhanced (DUD-E): better ligands and decoys for better benchmarking. J Med Chem 55:6582\u20136594. https:\/\/doi.org\/10.1021\/jm300687e","journal-title":"J Med Chem"},{"key":"10359_CR43","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1021\/acs.jcim.6b00283","volume":"56","author":"C Empereur-Mot","year":"2016","unstructured":"Empereur-Mot C, Zagury J-F, Montes M (2016) Screening explorer\u2014an interactive tool for the analysis of screening results. J Chem Inf Model 56:2281\u20132286. https:\/\/doi.org\/10.1021\/acs.jcim.6b00283","journal-title":"J Chem Inf Model"},{"key":"10359_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132:19\u201325. https:\/\/doi.org\/10.1016\/j.softx.2015.06.001","journal-title":"SoftwareX"},{"key":"10359_CR45","doi-asserted-by":"publisher","unstructured":"Lindahl E, Abraham MJ, Hess B, Spoel Dvd (2020) GROMACS 2020.6 Documentation (Release 2020.6). Zenodo. https:\/\/doi.org\/10.5281\/zenodo.4576060","DOI":"10.5281\/zenodo.4576060"},{"key":"10359_CR46","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/jcc.21816","volume":"32","author":"V Zoete","year":"2011","unstructured":"Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam: a fast force field generation tool for small organic molecules. J Comput Chem 32:2359\u20132368. https:\/\/doi.org\/10.1002\/jcc.21816","journal-title":"J Comput Chem"},{"key":"10359_CR47","doi-asserted-by":"publisher","DOI":"10.1063\/1.2408420","volume":"126","author":"G Bussi","year":"2007","unstructured":"Bussi G, Donadio D, Parrinello M (2007) Canonical sampling through velocity rescaling. J Chem Phys 126:014101. https:\/\/doi.org\/10.1063\/1.2408420","journal-title":"J Chem Phys"},{"key":"10359_CR48","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","volume":"52","author":"M Parrinello","year":"1981","unstructured":"Parrinello M, Rahman A (1981) Polymorphic transitions in single crystals: a new molecular dynamics method. J Appl Phys 52:7182\u20137190. https:\/\/doi.org\/10.1063\/1.328693","journal-title":"J Appl Phys"},{"key":"10359_CR49","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess B, Bekker H, Berendsen HJC, Fraaije JGEM (1997) LINCS: a linear constraint solver for molecular simulations. J Comput Chem 18:1463\u20131472. https:\/\/doi.org\/10.1002\/(SICI)1096-987X(199709)18:12%3c1463::AID-JCC4%3e3.0.CO;2-H","journal-title":"J Comput Chem"},{"key":"10359_CR50","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG (1995) A smooth particle mesh Ewald method. J Chem Phys 103:8577\u20138593. https:\/\/doi.org\/10.1063\/1.470117","journal-title":"J Chem Phys"},{"key":"10359_CR51","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"},{"key":"10359_CR52","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jmgm.2010.09.010","volume":"29","author":"T Rungrotmongkol","year":"2010","unstructured":"Rungrotmongkol T, Nunthaboot N, Malaisree M, Kaiyawet N, Yotmanee P, Meeprasert A, Hannongbua S (2010) Molecular insight into the specific binding of ADP-ribose to the nsP3 macro domains of chikungunya and venezuelan equine encephalitis viruses: Molecular dynamics simulations and free energy calculations. J Mol Graph Model 29:347\u2013353. https:\/\/doi.org\/10.1016\/j.jmgm.2010.09.010","journal-title":"J Mol Graph Model"},{"key":"10359_CR53","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.1c00645","author":"MS Vald\u00e9s-Tresanco","year":"2021","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E (2021) gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645","journal-title":"J Chem Theory Comput"},{"key":"10359_CR54","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, Hou T (2019) End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev 119:9478\u20139508. https:\/\/doi.org\/10.1021\/acs.chemrev.9b00055","journal-title":"Chem Rev"},{"key":"10359_CR55","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/prot.20033","volume":"55","author":"A Onufriev","year":"2004","unstructured":"Onufriev A, Bashford D, Case DA (2004) Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins 55:383\u2013394. https:\/\/doi.org\/10.1002\/prot.20033","journal-title":"Proteins"},{"key":"10359_CR56","unstructured":"Amber 2020 Reference Manual. https:\/\/ambermd.org\/Manuals.php. Accessed 18 May 2021"},{"key":"10359_CR57","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/s0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen VB, Arendall WB 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC (2010) MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 66:12\u201321. https:\/\/doi.org\/10.1107\/s0907444909042073","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10359_CR58","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1056-8719(00)00107-6","volume":"44","author":"CA Lipinski","year":"2000","unstructured":"Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235\u2013249. https:\/\/doi.org\/10.1016\/S1056-8719(00)00107-6","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10359_CR59","doi-asserted-by":"publisher","first-page":"456","DOI":"10.2174\/1389203715666140327114232","volume":"15","author":"SA Ali","year":"2014","unstructured":"Ali SA, Hassan MI, Islam A, Ahmad F (2014) A review of methods available to estimate solvent-accessible surface areas of soluble proteins in the folded and unfolded states. Curr Protein Pept Sci 15:456\u2013476. https:\/\/doi.org\/10.2174\/1389203715666140327114232","journal-title":"Curr Protein Pept Sci"},{"key":"10359_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100514","volume":"23","author":"M Borjian Boroujeni","year":"2021","unstructured":"Borjian Boroujeni M, Shahbazi Dastjerdeh M, Shokrgozar M, Rahimi H, Omidinia E (2021) Computational driven molecular dynamics simulation of keratinocyte growth factor behavior at different pH conditions. Inform Med Unlocked 23:100514. https:\/\/doi.org\/10.1016\/j.imu.2021.100514","journal-title":"Inform Med Unlocked"},{"key":"10359_CR61","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva NS, Galzitskaya OV (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628. https:\/\/doi.org\/10.1134\/S0026893308040195","journal-title":"Mol Biol"},{"key":"10359_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.apcsb.2015.09.004","volume-title":"Advances in protein chemistry and structural biology","author":"P Sneha","year":"2016","unstructured":"Sneha P, Doss CGP (2016) Chapter seven\u2014Molecular dynamics: new frontier in personalized medicine. In: Donev R (ed) Advances in protein chemistry and structural biology. Academic Press, pp 181\u2013224. https:\/\/doi.org\/10.1016\/bs.apcsb.2015.09.004"},{"key":"10359_CR63","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13321-018-0283-x","volume":"10","author":"J Dong","year":"2018","unstructured":"Dong J, Wang NN, Yao ZJ, Zhang L, Cheng Y, Ouyang D, Lu AP, Cao DS (2018) ADMETlab: a platform for systematic ADMET evaluation based on a comprehensively collected ADMET database. J Cheminform 10:29. https:\/\/doi.org\/10.1186\/s13321-018-0283-x","journal-title":"J Cheminform"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-021-10359-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-021-10359-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:44:01Z","timestamp":1744181041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-021-10359-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10359"],"URL":"https:\/\/doi.org\/10.1007\/s11030-021-10359-4","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"8 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}